Jeffrey M Schmitt

Title: Innovations by Jeffrey M Schmitt

Introduction

Jeffrey M Schmitt is an accomplished inventor based in Bolton, MA (US), known for his significant contributions to medical technology. He holds a total of four patents, showcasing his innovative approach to solving complex problems in the field.

Latest Patents

One of his latest patents is the "Internal secondary calculus fragmentation mechanism." This invention includes a calculi fracture device equipped with an acoustic transducer that transfers acoustic energy via a primary fragmentation probe. The device is designed to fracture a calculi mass into smaller fragments, with an evacuation tube connecting the probe to a pressure source. Additionally, it features a secondary fragmentation device located in the evacuation pathway to further break up the calculi fragments, thereby inhibiting clogging at a more proximal location in the evacuation pathway. Another notable patent is "Real-time composition analysis techniques for ultrasonic ablation." This invention allows for the estimation of the composition of a biological sample, such as patient tissue, during an ablation procedure. The composition detector system includes a probe, an illumination source, and a spectrometer, enabling real-time analysis of tissue composition.

Career Highlights

Throughout his career, Jeffrey has worked with notable companies, including Gyrus Acmi, Inc. and Olympus Surgical Technologies America. His work in these organizations has contributed to advancements in surgical technologies and medical devices.

Collaborations

Jeffrey has collaborated with several professionals in his field, including Charles Baker and Sergey A Bukesov. These collaborations have likely enhanced his innovative capabilities and contributed to the development of his patented technologies.

Conclusion

Jeffrey M Schmitt's work exemplifies the spirit of innovation in medical technology. His patents reflect a commitment to improving patient care through advanced medical devices and techniques.